Literature DB >> 8179304

Neurophysiological properties of pallidal neurons in Parkinson's disease.

D Sterio1, A Berić, M Dogali, E Fazzini, G Alfaro, O Devinsky.   

Abstract

Neuronal properties of the human globus pallidus (GP) are not known. Since GP is the major output of the basal ganglia, it may be involved in the pathophysiology of Parkinson's disease. We studied 12 patients with medically resistant Parkinson's disease by using single cell recording of the GP during stereotaxic pallidotomy to define neuronal firing rate and its modulation during active and passive movements. Different frequency and pattern of single cell activity was found in globus pallidus externus compared with globus pallidus internus. Discharge rates of 19% of GP cells were modulated by passive contralateral movements. Pallidal units were most often related solely to single joint movement. Different patterns of activity in relation to the two different movements of the same joint were often observed. We identified somatotopically arranged cell clusters that alter discharge rate with related movements. These findings suggest at least a partial somatotopic organization of the human GP and similarity with experimental results in both healthy and MPTP monkeys, providing a rationale for surgical or pharmacological targeting of GP for treating Parkinson's disease.

Entities:  

Mesh:

Year:  1994        PMID: 8179304     DOI: 10.1002/ana.410350512

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

Review 1.  Deep brain stimulation: overview and update.

Authors:  Martin L Bootin
Journal:  J Clin Monit Comput       Date:  2006-09-02       Impact factor: 2.502

2.  Presynaptic actions of D2-like receptors in the rat cortico-striato-globus pallidus disynaptic connection in vitro.

Authors:  Katsushige Watanabe; Takako Kita; Hitoshi Kita
Journal:  J Neurophysiol       Date:  2008-12-10       Impact factor: 2.714

3.  Globus pallidus internus firing rate modification after motor-imagination in three Parkinson's disease patients.

Authors:  Ramón Leiguarda; Daniel Cerquetti; Eduardo Tenca; Marcelo Merello
Journal:  J Neural Transm (Vienna)       Date:  2009-03-10       Impact factor: 3.575

4.  Cognitive functioning after pallidotomy for refractory Parkinson's disease.

Authors:  K Perrine; M Dogali; E Fazzini; D Sterio; E Kolodny; D Eidelberg; O Devinsky; A Beric
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

5.  European Society for Stereotactic and Functional Neurosurgery. Milan, Italy, June 12-15, 1996. Abstracts.

Authors: 
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  Dispersed activity during passive movement in the globus pallidus of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated primate.

Authors:  Yaara Erez; Hadass Tischler; Katya Belelovsky; Izhar Bar-Gad
Journal:  PLoS One       Date:  2011-01-18       Impact factor: 3.240

7.  Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease.

Authors:  P Brown; A Oliviero; P Mazzone; A Insola; P Tonali; V Di Lazzaro
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

8.  Firing rates of pallidal neurons are similar in Huntington's and Parkinson's disease patients.

Authors:  Joyce K H Tang; Elena Moro; Andres M Lozano; Anthony E Lang; William D Hutchison; Neil Mahant; Jonathan O Dostrovsky
Journal:  Exp Brain Res       Date:  2005-08-05       Impact factor: 1.972

9.  Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and internal globus pallidus activity. Short communication.

Authors:  A Stefani; P Stanzione; A Bassi; P Mazzone; T Vangelista; G Bernardi
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

10.  Somatotopic organization in the internal segment of the globus pallidus in Parkinson's disease.

Authors:  Kenneth B Baker; John Y K Lee; Gaurav Mavinkurve; Gary S Russo; Benjamin Walter; Mahlon R DeLong; Roy A E Bakay; Jerrold L Vitek
Journal:  Exp Neurol       Date:  2010-01-06       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.